Correlation Between Eyenovia and Reviva Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Eyenovia and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Reviva Pharmaceuticals.

Diversification Opportunities for Eyenovia and Reviva Pharmaceuticals

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Eyenovia and Reviva is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Eyenovia i.e., Eyenovia and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between Eyenovia and Reviva Pharmaceuticals

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Reviva Pharmaceuticals. In addition to that, Eyenovia is 1.75 times more volatile than Reviva Pharmaceuticals Holdings. It trades about -0.12 of its total potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.03 per unit of volatility. If you would invest  124.00  in Reviva Pharmaceuticals Holdings on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Reviva Pharmaceuticals Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Reviva Pharmaceuticals Holding

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Reviva Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Eyenovia and Reviva Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Reviva Pharmaceuticals

The main advantage of trading using opposite Eyenovia and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.
The idea behind Eyenovia and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume